Related Experiment Video
Updated: Jun 6, 2026

Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation
Published on: July 23, 2012
The emerging role of microRNAs in multiple sclerosis
Andreas Junker1, Reinhard Hohlfeld, Edgar Meinl
1Department of Neuropathology, University Medical Center, Georg August University, Robert-Koch-Strasse 40, 37075 Göttingen, Germany.
Abstract:
Several hundred microRNAs (miRNAs) fine-tune the expression of approximately half of all human genes. Recent studies have revealed that miRNA profiles in blood cells become altered in multiple sclerosis (MS), and that active and inactive MS lesions have distinct miRNA expression patterns. The dysregulated miRNAs in MS lesions seem to be associated with astrocytes and infiltrating immune cells, and might unleash local macrophages through downregulation of the self-recognition signal CD47. The expression of miRNA-326 in blood cells has been reported to increase during relapses. This miRNA promotes T helper 17 cell differentiation and is highly abundant in active MS lesions. miRNAs are needed for maintenance of the myelin sheath, and the absence of such molecules results in axonal damage in mice. miRNA-219 and other miRNAs promote oligodendrocyte differentiation. Here, we discuss the possible contribution of miRNAs to MS pathogenesis. An improved understanding of this contribution should help to identify novel therapeutic targets and biomarkers for this disease.
Insights
MicroRNAs (miRNAs) play a role in multiple sclerosis (MS) pathogenesis by altering immune cell function and myelin maintenance. Understanding these miRNA changes could lead to new MS therapies and biomarkers.
Area of Science:
- Neuroimmunology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) are crucial regulators of gene expression, influencing numerous biological processes.
- Altered miRNA profiles are observed in multiple sclerosis (MS) patients' blood cells and lesions.
- Specific miRNAs are implicated in the immune responses and myelin sheath maintenance relevant to MS.
Purpose of the Study:
- To discuss the potential role of miRNAs in the pathogenesis of multiple sclerosis (MS).
- To explore how dysregulated miRNAs contribute to MS pathology, including immune cell involvement and myelin damage.
- To highlight the potential of miRNAs as therapeutic targets and biomarkers for MS.
Main Methods:
- Review of recent studies on miRNA expression in multiple sclerosis.
- Analysis of miRNA profiles in blood cells and MS lesions.
- Discussion of the functional roles of specific miRNAs (e.g., miRNA-326, miRNA-219) in immune cells and oligodendrocytes.
Main Results:
- Distinct miRNA expression patterns exist in active versus inactive MS lesions.
- Dysregulated miRNAs in MS lesions are linked to astrocytes and immune cells, potentially affecting macrophage activity via CD47.
- Increased miRNA-326 in blood during relapses correlates with T helper 17 cell differentiation and is found in active MS lesions.
- miRNAs are essential for myelin sheath maintenance; their absence causes axonal damage.
- miRNA-219 and others promote oligodendrocyte differentiation.
Conclusions:
- MicroRNAs are significantly implicated in multiple sclerosis pathogenesis.
- Dysregulation of specific miRNAs contributes to immune dysregulation and myelin damage in MS.
- Further understanding of miRNA involvement may reveal novel therapeutic strategies and diagnostic biomarkers for MS.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Multiple Sclerosis l: Introduction
